MétaCan
Menu
Back to cohort
Record W3004209283 · doi:10.1016/j.ejca.2019.11.013

The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients

2020· review· en· W3004209283 on OpenAlexaff
Ben Alman, Steven Attia, Christina Baumgarten, Charlotte Benson, Jean‐Yves Blay, Sylvie Bonvalot, Jessica Breuing, Ken Cardona, Paolo G. Casali, Frits van Coevorden, Chiara Colombo, Angelo Paolo Dei Tos, Palma Dileo, Andrea Ferrari, Marco Fiore, Anna Maria Frezza, J. Santiago García, Rebecca A. Gladdy, Mrinal M. Gounder, Alessandro Gronchi, Rick L. Haas, Sam Hackett, Florian Haller, Peter Hohenberger, Olga Husson, Robin L. Jones, Ian Judson, Bernd Kasper, Akira Kawai, Vlada Kogosov, Alex J. Lazar, Robert G. Maki, Tim Mathes, Christina Messiou, Fariba Navid, Yoshihiro Nishida, Elena Palassini, Nicolas Penel, Robert Pollock, Dawid Pieper, Marlene Portnoy, Chandrajit P. Raut, Evelyne Roets, Sergio Sandrucci, Marta Sbaraglia, Silvia Stacchiotti, Katherine A. Thornton, Winette van der Graaf, Kim van der Zande, Winan J. van Houdt, Víctor M. Villalobos, Andrew J. Wagner, Eva Wardelmann, Markus Wartenberg, Sarah Watson, Aaron R. Weiss, Nikolaos Zafiropoulos

Bibliographic record

VenueEuropean Journal of Cancer · 2020
Typereview
Languageen
FieldMedicine
TopicSoft tissue tumor case studies
Canadian institutionsPrincess Margaret Cancer CentreMount Sinai HospitalUniversity of Toronto
FundersJanssen BiotechSpringworks TherapeuticsNovartisPharmaMarDesmoid Tumor Research FoundationBayerEli Lilly and CompanyIgnytaAbbVie
KeywordsGuidelineMedicineFibromatosisSarcomaSoft tissue sarcomaSoft tissueIntensive care medicineSurgeryPathology

Abstract

fetched live from OpenAlex

Desmoid tumor (DT; other synonymously used terms: Desmoid-type fibromatosis, aggressive fibromatosis) is a rare and locally aggressive monoclonal, fibroblastic proliferation characterised by a variable and often unpredictable clinical course. Previously surgery was the standard primary treatment modality; however, in recent years a paradigm shift towards a more conservative management has been introduced and an effort to harmonise the strategy amongst clinicians has been made. We present herein an evidence-based, joint global consensus guideline approach to the management of this disease focussing on: molecular genetics, indications for an active treatment, and available systemic therapeutic options. This paper follows a one-day consensus meeting held in Milan, Italy, in June 2018 under the auspices of the European Reference Network for rare solid adult cancers, EURACAN, the European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) as well as Sarcoma Patients EuroNet (SPAEN) and The Desmoid tumour Research Foundation (DTRF). The meeting brought together over 50 adult and pediatric sarcoma experts from different disciplines, patients and patient advocates from Europe, North America and Japan.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.010
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.009
Threshold uncertainty score0.034

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.010
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0030.002
Bibliometrics0.0060.004
Science and technology studies0.0010.001
Scholarly communication0.0020.002
Open science0.0030.002
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.049
GPT teacher head0.341
Teacher spread0.292 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations478
Published2020
Admission routes1
Has abstractno

Explore more

Same venueEuropean Journal of CancerSame topicSoft tissue tumor case studiesFrench-language works237,207